Skip to Content


Andrew Joseph, quoting Rachel Sachs (Academic Fellow Alumna)
Stat
May 11, 2018

Read the Full Article

From the article:

Given that President Trump is famous for his Earth-shaking tweets, it seems appropriate to comb through Twitter reactions to his administration’s new drug pricing plan, which was unveiled Friday.

Many experts, analysts, and journalists noted the lack of detail in the proposals and the disconnect between Trump’s harsh words against drug makers and pharmacy benefit managers versus how the plan could actually affect industry players. They also pointed out that this plan is just that — any actual changes would need future regulatory moves or congressional action.

"Watching the speech now, but on first glance some of the "immediate actions" in the admin's drug pricing proposals are... not immediate. And the "further opportunities" even less so. It's not going to take effect "very soon," as POTUS just said" tweets Rachel Sachs

Read the full article here!

Read the Full Article

Tags

pharmaceuticals   rachel sachs   regulation